# ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

> **NCT03130777** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 86 (actual)

## Conditions studied

- Pulmonary Disease
- Transcatheter Pulmonary Valve Replacement (TPVR)
- Tetralogy of Fallot
- Congenital Heart Disease
- Pulmonary Regurgitation

## Interventions

- **DEVICE:** Edwards Alterra Adaptive Prestent with SAPIEN 3 THV

## Key facts

- **NCT ID:** NCT03130777
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-08-22
- **Primary completion:** 2022-07-14
- **Final completion:** 2032-06
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130777, "ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03130777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*